Michael Kauffman is of Adicet Bio, Inc.. Currently has a direct ownership of 5,900 shares of ACET, which is worth approximately $6,608. The most recent transaction as insider was on Jun 05, 2024, when has been sold 5,900 shares (Common Stock) at a price of $1.43 per share, resulting in proceeds of $8,437. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.9K
0% 3M change
0% 12M change
Total Value Held $6,608

Michael Kauffman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
SELL
Open market or private sale
$8,437 $1.43 p/Share
5,900 Reduced 50.0%
5,900 Common Stock
Jun 05 2024
BUY
Grant, award, or other acquisition
-
5,900 Added 33.33%
11,800 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
5,900 Added 50.0%
5,900 Common Stock

Also insider at

KPTI
Karyopharm Therapeutics Inc. Healthcare
KZR
Kezar Life Sciences, Inc. Healthcare
VSTM
Verastem, Inc. Healthcare
MK

Michael Kauffman

Newton, MA

Track Institutional and Insider Activities on ACET

Follow Adicet Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACET shares.

Notify only if

Insider Trading

Get notified when an Adicet Bio, Inc. insider buys or sells ACET shares.

Notify only if

News

Receive news related to Adicet Bio, Inc.

Track Activities on ACET